(AVGO) Broadcom - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US11135F1012

Semiconductors, Ethernet, Wi-Fi, Infrastructure Software

Dividends

Dividend Yield 0.69%
Yield on Cost 5y 6.20%
Yield CAGR 5y -3.41%
Payout Consistency 94.2%
Payout Ratio 35.5%
Risk via 5d forecast
Volatility 73.4%
Value at Risk 5%th 106%
Relative Tail Risk -12.34%
Reward TTM
Sharpe Ratio 1.30
Alpha 66.23
CAGR/Max DD 2.12
Character TTM
Hurst Exponent 0.406
Beta 1.829
Beta Downside 1.921
Drawdowns 3y
Max DD 41.15%
Mean DD 6.51%
Median DD 4.55%

Description: AVGO Broadcom December 02, 2025

Broadcom Inc. (NASDAQ:AVGO) designs, develops, and supplies a broad portfolio of semiconductor devices and infrastructure-software solutions, organized into two primary segments: Semiconductor Solutions and Infrastructure Software. Its product slate spans Ethernet switching and routing silicon, optical and copper PHYs, fiber-optic transceivers, set-top-box SoCs, DSL/PON access chips, Wi-Fi/Bluetooth/GNSS SoCs, RF front-end modules, custom flash controllers, and a range of industrial and medical sensors, among others. These components power enterprise and data-center networking (including AI-focused networking), consumer broadband, smartphones, base stations, factory automation, power-generation equipment, and electronic displays.

Key recent metrics: FY 2023 revenue reached approximately **$37.5 billion**, delivering an operating margin near **35 %**, and the company generated **$13 billion** of free cash flow, supporting a **~3.5 % dividend yield** and ongoing share-repurchase programs. Broadcom’s backlog growth in 2024 is projected at **8-10 % YoY**, driven largely by data-center and 5G infrastructure demand.

Macro-level drivers shaping Broadcom’s outlook include: (1) **Accelerating AI workloads** that boost demand for high-speed Ethernet and custom silicon; (2) **5G rollout and edge-computing expansion**, increasing orders for RF front-end modules and connectivity chips; and (3) **Supply-chain normalization** after the 2020-2022 chip shortage, which is easing lead-times and allowing the company to capture market share through its diversified product mix.

For a deeper quantitative assessment, you may find ValueRay’s analyst toolkit useful.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (23.13b TTM) > 0 and > 6% of Revenue (6% = 3.83b TTM)
FCFTA 0.16 (>2.0%) and ΔFCFTA 4.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 20.44% (prev 5.62%; Δ 14.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.16 (>3.0%) and CFO 27.54b > Net Income 23.13b (YES >=105%, WARN >=100%)
Net Debt (48.96b) to EBITDA (34.22b) ratio: 1.43 <= 3.0 (WARN <= 3.5)
Current Ratio 1.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (4.89b) change vs 12m ago 1.26% (target <= -2.0% for YES)
Gross Margin 67.77% (prev 63.03%; Δ 4.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 37.94% (prev 31.14%; Δ 6.81pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 8.09 (EBITDA TTM 34.22b / Interest Expense TTM 3.16b) >= 6 (WARN >= 3)

Altman Z'' 1.82

(A) 0.08 = (Total Current Assets 31.57b - Total Current Liabilities 18.51b) / Total Assets 171.09b
(B) 0.06 = Retained Earnings (Balance) 9.76b / Total Assets 171.09b
(C) 0.15 = EBIT TTM 25.55b / Avg Total Assets 168.37b
(D) 0.11 = Book Value of Equity 9.98b / Total Liabilities 89.80b
Total Rating: 1.82 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 91.07

1. Piotroski 7.50pt
2. FCF Yield 1.54%
3. FCF Margin 42.13%
4. Debt/Equity 0.80
5. Debt/Ebitda 1.43
6. ROIC - WACC (= 10.81)%
7. RoE 31.47%
8. Rev. Trend 97.00%
9. EPS Trend 95.08%

What is the price of AVGO shares?

As of December 17, 2025, the stock is trading at USD 339.81 with a total of 65,700,989 shares traded.
Over the past week, the price has changed by -15.28%, over one month by -0.83%, over three months by -6.51% and over the past year by +37.26%.

Is AVGO a buy, sell or hold?

Broadcom has received a consensus analysts rating of 4.60. Therefore, it is recommended to buy AVGO.
  • Strong Buy: 30
  • Buy: 7
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the AVGO price?

Issuer Target Up/Down from current
Wallstreet Target Price 444.9 30.9%
Analysts Target Price 444.9 30.9%
ValueRay Target Price 591.5 74.1%

AVGO Fundamental Data Overview December 13, 2025

Market Cap USD = 1699.72b (1699.72b USD * 1.0 USD.USD)
P/E Trailing = 85.4941
P/E Forward = 43.29
P/S = 26.6051
P/B = 23.6066
P/EG = 0.6119
Beta = 1.204
Revenue TTM = 63.89b USD
EBIT TTM = 25.55b USD
EBITDA TTM = 34.22b USD
Long Term Debt = 62.82b USD (from longTermDebt, two quarters ago)
Short Term Debt = 3.15b USD (from shortTermDebt, last quarter)
Debt = 65.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 48.96b USD (from netDebt column, last quarter)
Enterprise Value = 1748.68b USD (1699.72b + Debt 65.14b - CCE 16.18b)
Interest Coverage Ratio = 8.09 (Ebit TTM 25.55b / Interest Expense TTM 3.16b)
FCF Yield = 1.54% (FCF TTM 26.91b / Enterprise Value 1748.68b)
FCF Margin = 42.13% (FCF TTM 26.91b / Revenue TTM 63.89b)
Net Margin = 36.20% (Net Income TTM 23.13b / Revenue TTM 63.89b)
Gross Margin = 67.77% ((Revenue TTM 63.89b - Cost of Revenue TTM 20.59b) / Revenue TTM)
Gross Margin QoQ = 67.99% (prev 67.10%)
Tobins Q-Ratio = 10.22 (Enterprise Value 1748.68b / Total Assets 171.09b)
Interest Expense / Debt = 1.17% (Interest Expense 761.0m / Debt 65.14b)
Taxrate = -24.01% (negative due to tax credits) (-1.65b / 6.87b)
NOPAT = 31.68b (EBIT 25.55b * (1 - -24.01%)) [negative tax rate / tax credits]
Current Ratio = 1.71 (Total Current Assets 31.57b / Total Current Liabilities 18.51b)
Debt / Equity = 0.80 (Debt 65.14b / totalStockholderEquity, last quarter 81.29b)
Debt / EBITDA = 1.43 (Net Debt 48.96b / EBITDA 34.22b)
Debt / FCF = 1.82 (Net Debt 48.96b / FCF TTM 26.91b)
Total Stockholder Equity = 73.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.52% (Net Income 23.13b / Total Assets 171.09b)
RoE = 31.47% (Net Income TTM 23.13b / Total Stockholder Equity 73.49b)
RoCE = 18.74% (EBIT 25.55b / Capital Employed (Equity 73.49b + L.T.Debt 62.82b))
RoIC = 23.14% (NOPAT 31.68b / Invested Capital 136.90b)
WACC = 12.33% (E(1699.72b)/V(1764.86b) * Re(12.75%) + D(65.14b)/V(1764.86b) * Rd(1.17%) * (1-Tc(-0.24)))
Discount Rate = 12.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.00%
[DCF Debug] Terminal Value 65.18% ; FCFE base≈23.91b ; Y1≈26.63b ; Y5≈35.04b
Fair Price DCF = 66.00 (DCF Value 311.68b / Shares Outstanding 4.72b; 5y FCF grow 13.12% → 3.0% )
EPS Correlation: 95.08 | EPS CAGR: 25.22% | SUE: 2.69 | # QB: 2
Revenue Correlation: 97.00 | Revenue CAGR: 25.41% | SUE: 1.65 | # QB: 1
EPS next Quarter (2026-01-31): EPS=2.01 | Chg30d=+0.038 | Revisions Net=+1 | Analysts=32
EPS current Year (2026-10-31): EPS=10.00 | Chg30d=+0.719 | Revisions Net=+5 | Growth EPS=+46.6% | Growth Revenue=+49.3%
EPS next Year (2027-10-31): EPS=13.57 | Chg30d=+1.329 | Revisions Net=+6 | Growth EPS=+35.7% | Growth Revenue=+30.9%

Additional Sources for AVGO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle